188 related articles for article (PubMed ID: 38413979)
1. Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.
Naro C; Antonioni A; Medici V; Caggiano C; Jolly A; de la Grange P; Bielli P; Paronetto MP; Sette C
J Exp Clin Cancer Res; 2024 Feb; 43(1):58. PubMed ID: 38413979
[TBL] [Abstract][Full Text] [Related]
2. Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells.
Anufrieva KS; Shender VО; Arapidi GP; Pavlyukov MS; Shakhparonov MI; Shnaider PV; Butenko IO; Lagarkova MA; Govorun VM
Genome Med; 2018 Jun; 10(1):49. PubMed ID: 29950180
[TBL] [Abstract][Full Text] [Related]
3. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.
Zhang D; Hu Q; Liu X; Ji Y; Chao HP; Liu Y; Tracz A; Kirk J; Buonamici S; Zhu P; Wang J; Liu S; Tang DG
Nat Commun; 2020 Apr; 11(1):2089. PubMed ID: 32350277
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer.
Frei K; Schecher S; Daher T; Hörner N; Richter J; Hildebrand U; Schindeldecker M; Witzel HR; Tsaur I; Porubsky S; Gaida MM; Roth W; Tagscherer KE
Int J Cancer; 2024 Mar; 154(6):1082-1096. PubMed ID: 37916780
[TBL] [Abstract][Full Text] [Related]
5. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
[TBL] [Abstract][Full Text] [Related]
6. Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
Kumar D; Kashyap MK; Yu Z; Spaanderman I; Villa R; Kipps TJ; La Clair JJ; Burkart MD; Castro JE
Aging (Albany NY); 2022 Mar; 14(5):2081-2100. PubMed ID: 35230971
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy.
Quick J; Santos ND; Cheng MHY; Chander N; Brimacombe CA; Kulkarni J; van der Meel R; Tam YYC; Witzigmann D; Cullis PR
J Control Release; 2022 Sep; 349():174-183. PubMed ID: 35780952
[TBL] [Abstract][Full Text] [Related]
9. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
F1000Res; 2018; 7():1189. PubMed ID: 30271587
[No Abstract] [Full Text] [Related]
10. Unannotated splicing regulatory elements in deep intron space.
Conboy JG
Wiley Interdiscip Rev RNA; 2021 Sep; 12(5):e1656. PubMed ID: 33887804
[TBL] [Abstract][Full Text] [Related]
11. Pre-mRNA splicing repression triggers abiotic stress signaling in plants.
Ling Y; Alshareef S; Butt H; Lozano-Juste J; Li L; Galal AA; Moustafa A; Momin AA; Tashkandi M; Richardson DN; Fujii H; Arold S; Rodriguez PL; Duque P; Mahfouz MM
Plant J; 2017 Jan; 89(2):291-309. PubMed ID: 27664942
[TBL] [Abstract][Full Text] [Related]
12. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
Chellini L; Pieraccioli M; Sette C; Paronetto MP
J Exp Clin Cancer Res; 2022 May; 41(1):178. PubMed ID: 35590370
[TBL] [Abstract][Full Text] [Related]
13. Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns.
Olthof AM; Hyatt KC; Kanadia RN
BMC Genomics; 2019 Aug; 20(1):686. PubMed ID: 31470809
[TBL] [Abstract][Full Text] [Related]
14. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
15. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells.
Melnyk JE; Steri V; Nguyen HG; Hann B; Feng FY; Shokat KM
Bioorg Med Chem; 2020 Oct; 28(20):115712. PubMed ID: 33069070
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Cesari E; Ciucci A; Pieraccioli M; Caggiano C; Nero C; Bonvissuto D; Sillano F; Buttarelli M; Piermattei A; Loverro M; Camarda F; Greco V; De Bonis M; Minucci A; Gallo D; Urbani A; Vizzielli G; Scambia G; Sette C
J Exp Clin Cancer Res; 2023 May; 42(1):126. PubMed ID: 37202753
[TBL] [Abstract][Full Text] [Related]
17. KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
Liu X; Gomez-Pinillos A; Loder C; Carrillo-de Santa Pau E; Qiao R; Unger PD; Kurek R; Oddoux C; Melamed J; Gallagher RE; Mandeli J; Ferrari AC
Am J Pathol; 2012 Sep; 181(3):1007-16. PubMed ID: 22819534
[TBL] [Abstract][Full Text] [Related]
18. The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA.
Cho V; Mei Y; Sanny A; Chan S; Enders A; Bertram EM; Tan A; Goodnow CC; Andrews TD
Genome Biol; 2014 Jan; 15(1):R26. PubMed ID: 24476532
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.
Chen X; Yang HT; Zhang B; Phillips JW; Cheng D; Rigo F; Witte ON; Xing Y; Black DL
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2220190120. PubMed ID: 37399401
[TBL] [Abstract][Full Text] [Related]
20. Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer.
Lee AR; Gan Y; Xie N; Ramnarine VR; Lovnicki JM; Dong X
Cancer Sci; 2019 Jan; 110(1):245-255. PubMed ID: 30417466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
